Sauzanne Khalilieh - Concepedia

Author

Sauzanne Khalilieh

Merck & Co., Inc., Rahway, NJ, USA (United States)ORCID

Also Known As

Robert Blanks, S. Khalilieh, Sauzanne G. Khalilieh, Sauzanne Khalilieh, sauzanne Khalilieh

Publications

1.1K

Citations

H-Index

Concepts

All Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)Celerion (United States)Medica (United States)Orlando Clinical Research Center Pharma Medica Research (Canada)

About

Sauzanne Khalilieh is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, pharmacology, and inflammation.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	505
2	Pharmacology	5	5	288
3	Immunology	3	3	399
4	Allergy	1	1	12
5	Pulmonary Disease	1	1	182

Sauzanne Khalilieh

Publications

Citations

H-Index

Page 1

	Year	Citations
Clinical improvement in psoriasis with specific targeting of interleukin-23 Tamara Kopp, Elisabeth Riedl, Christine Bangert, Nature Autoimmune DiseaseMedicineClinical ImprovementImmunologyClinical Dermatology	2015	205
SCH527123, a novel CXCR2 antagonist, inhibits ozone-induced neutrophilia in healthy subjects Olaf Holz, Sauzanne Khalilieh, Andrea Ludwig-Sengpiel, European Respiratory Journal Acute Lung InjuryInflammatory Lung DiseaseHealthy SubjectsLung InflammationImmunology	2009	182
Niacin Lipid Efficacy Is Independent of Both the Niacin Receptor GPR109A and Free Fatty Acid Suppression Brett Lauring, Andrew K.P. Taggart, James R. Tata, Science Translational Medicine	2012	125
Characterisation of the absorption, distribution, metabolism, excretion and mass balance of doravirine, a non-nucleoside reverse transcriptase inhibitor in humans Rosa I. Sánchez, Kerry L. Fillgrove, Ka Lai Yee, Xenobiotica	2018	56
The Effect of Single and Multiple Doses of Rifampin on the Pharmacokinetics of Doravirine in Healthy Subjects Ka Lai Yee, Sauzanne Khalilieh, Rosa I. Sánchez, Clinical Drug Investigation Healthy SubjectsPharmacodynamicsMultiple DosesMedicinePharmacological Study	2017	46
Results of a Doravirine-Atorvastatin Drug-Drug Interaction Study Sauzanne Khalilieh, Ka Lai Yee, Rosa I. Sánchez, Antimicrobial Agents and Chemotherapy	2016	44
Pharmacokinetics of Tildrakizumab (MK‐3222), an Anti‐IL‐23 Monoclonal Antibody, After Intravenous or Subcutaneous Administration in Healthy Subjects Sauzanne Khalilieh, Peter Hodsman, Christine Xu, Basic & Clinical Pharmacology & Toxicology	2018	35
Multiple Doses of Rifabutin Reduce Exposure of Doravirine in Healthy Subjects Sauzanne Khalilieh, Ka Lai Yee, Rosa I. Sánchez, The Journal of Clinical Pharmacology	2018	35
Effect of tildrakizumab (MK‐3222), a high affinity, selective anti‐IL23p19 monoclonal antibody, on cytochrome P450 metabolism in subjects with moderate to severe psoriasis Sauzanne Khalilieh, Azher Hussain, Diana Montgomery, British Journal of Clinical Pharmacology	2018	33
Pharmacokinetics of desloratadine in children between 2 and 11 years of age Samir K. Gupta, Sauzanne Khalilieh, Bhavna Kantesaria, British Journal of Clinical Pharmacology	2006	32

Page 1